Diversity and inclusion in oncology clinical trials
Clarify Health
OCTOBER 26, 2021
Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. To advance equity in clinical research, the U.S.
52 
Let's personalize your content